|
|||||
|
|
Unfinished business: Incomplete laminin processing exposes a tumor target |
|
| Abstract: | The G45 domain of laminin-332 is cleaved in normal tissues but remains in squamous cell carcinomas. Targeting this domain using a G45 antibody reduced in vivo tumor growth and invasion and suggests a role for G45 as a new therapeutic target. |
| Keywords: | |